Pavmed Inc Stock Analysis

PAVmed Stock Analysis Notes

About 18.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.2. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PAVmed Inc recorded a loss per share of 12.0. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 2nd of January 2026. PAVmed Inc. operates as a medical device company in the United States. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. Pavmed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 89 people. To find out more about PAVmed Inc contact Lishan MD at 917 813 1828 or learn more at https://www.pavmed.com.

PAVmed Inc Investment Alerts

PAVmed Largest EPS Surprises

View All Earnings Estimates

PAVmed Environmental, Social, and Governance (ESG) Scores

PAVmed Stock Institutional Investors

Note, although PAVmed's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

PAVmed Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.95 M.

PAVmed Profitablity

The company has Profit Margin (PM) of 106.72 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (968.8) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $968.8.

Management Efficiency

PAVmed Inc has return on total asset (ROA) of (0.3678) % which means that it has lost $0.3678 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1744 %, meaning that it created $0.1744 on every $100 dollars invested by stockholders. PAVmed's management efficiency ratios could be used to measure how well PAVmed manages its routine affairs as well as how well it operates its assets and liabilities. At this time, PAVmed's Return On Tangible Assets are very stable compared to the past year. As of the 10th of February 2026, Return On Assets is likely to grow to 1.23, while Return On Capital Employed is likely to drop 6.16. At this time, PAVmed's Other Current Assets are very stable compared to the past year. As of the 10th of February 2026, Non Current Assets Total is likely to grow to about 34.4 M, though Net Tangible Assets are likely to grow to (17.3 M).

Technical Drivers

As of the 10th of February, PAVmed holds the Coefficient Of Variation of 2048.51, market risk adjusted performance of 0.1652, and Mean Deviation of 7.43. Concerning fundamental indicators, the technical analysis model allows you to check practical technical drivers of PAVmed, as well as the relationship between them. Please check PAVmed Inc jensen alpha and downside variance to decide if PAVmed Inc is priced more or less accurately, providing market reflects its current price of 10.95 per share. Given that PAVmed has jensen alpha of 0.2923, we recommend you to check out PAVmed Inc's recent market performance to make sure the company can sustain itself at some point in the future.

PAVmed Inc Price Movement Analysis

PAVmed Inc Insider Trading Activities

PAVmed Outstanding Bonds

PAVmed Predictive Daily Indicators

PAVmed Corporate Filings

PAVmed Forecast Models

PAVmed's time-series forecasting models are one of many PAVmed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PAVmed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

PAVmed Bond Ratings

PAVmed Inc financial ratings play a critical role in determining how much PAVmed have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for PAVmed's borrowing costs.

PAVmed Inc Debt to Cash Allocation

PAVmed Inc currently holds 31.86 M in liabilities with Debt to Equity (D/E) ratio of 0.79, which is about average as compared to similar companies. PAVmed Inc has a current ratio of 1.78, which is within standard range for the sector. Note, when we think about PAVmed's use of debt, we should always consider it together with its cash and equity.

PAVmed Total Assets Over Time

PAVmed Assets Financed by Debt

The debt-to-assets ratio shows the degree to which PAVmed uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

PAVmed Debt Ratio

82.0

It appears that most of the PAVmed's assets are financed through debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the PAVmed's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of PAVmed, which in turn will lower the firm's financial flexibility.

PAVmed Corporate Bonds Issued

PAVmed Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how PAVmed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PAVmed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as PAVmed. By using and applying PAVmed Stock analysis, traders can create a robust methodology for identifying PAVmed entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. PAVmed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. PAVmed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

PAVmed Inc stock analysis indicators help investors evaluate how PAVmed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading PAVmed shares will generate the highest return on investment. By understating and applying PAVmed stock analysis, traders can identify PAVmed position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value - what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.

It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.